BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,920,000 | +42.9% | 237,616 | +37.7% | 2.40% | +7.5% |
| Q2 2022 | $25,139,000 | +6345.9% | 172,525 | +2775.4% | 2.24% | +2440.9% |
| Q3 2020 | $390,000 | -11.2% | 6,000 | 0.0% | 0.09% | -11.1% |
| Q2 2020 | $439,000 | +61.4% | 6,000 | -25.0% | 0.10% | +94.1% |
| Q1 2020 | $272,000 | -79.2% | 8,000 | -66.7% | 0.05% | -48.5% |
| Q4 2019 | $1,307,000 | +13.9% | 24,000 | -12.7% | 0.10% | +37.5% |
| Q3 2019 | $1,147,000 | – | 27,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |